Note 14 - Segment and Geographic Information

9 Months Ended

Sep. 30, 2015

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

14.     Segment and Geographic Information

The Company has one reportable operating segment, for the purposes of assessing performance and deciding how to allocate resources.

Product revenue by product group is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Orthobiologics	$	20,461,181	$	18,899,873	$	51,716,600	$	48,750,277
Dermal		412,357		401,355		1,131,657		938,966
Surgical		1,413,039		1,452,946		4,449,639		4,581,496
Ophthalmic		344,119		366,138		1,263,582		938,134
Veterinary		1,045,000		855,000		3,526,932		2,385,000
	$	23,675,696	$	21,975,312	$	62,088,410	$	57,593,873

Total revenue by geographic location and as a percentage of overall total revenue for the three- and nine-month periods ended September 30, 2015 and 2014 are as follows:

	Three Months Ended September 30,
	2015					2014
	Total Revenue		Percentage of Revenue			Total Revenue		Percentage of Revenue
Geographic Location:
United States	$	19,239,247		81	%	$	18,455,167		84	%
Europe		1,976,751		8	%		1,784,414		8	%
Other		2,465,259		11	%		1,815,842		8	%
Total	$	23,681,257		100	%	$	22,055,423		100	%

	Nine Months Ended September 30,
	2015					2014
	Total Revenue		Percentage of Revenue			Total Revenue		Percentage of Revenue
Geographic Location:
United States	$	51,048,132		82	%	$	72,935,722		89	%
Europe		6,293,965		10	%		5,274,071		6	%
Other		4,763,045		8	%		4,130,577		5	%
Total	$	62,105,142		100	%	$	82,340,370		100	%